Uses
Technetium Tc 99m Medronate Injection may be used as a bone imaging agent to delineate areas of altered osteogenesis.
Source: US FDA prescribing information
Molecule
Technetium tc-99m medronate
Radioactive Diagnostic Agent
Available on request
- Presentations
- 2
- Brands
- 1
- Manufacturers
- 2
- Available from stock
- 0
Technetium tc-99m medronate is a radioactive diagnostic agent. It is available as powder for injection for intravenous use. MedsAcross supplies Technetium tc-99m medronate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Key facts
- Pharmacological class
- Radioactive Diagnostic Agent, Radiopharmaceutical Activity
- US FDA first approval
- 28 November 1978
- EU status
- Not recorded
- Orphan designation
- Not recorded
- WHO essential medicine
- Not recorded
- India (CDSCO)
- Not yet confirmed against CDSCO approval lists
- Routes
- Intravenous
- Dosage forms
- Powder for injection
- Identifiers
- UNII X89XV46R07
Clinical information
From the regulator-approved product information. Each section names its source.
Dosing overview
DOSAGES AND ADMINISTRATION: Shielding should be utilized when preparing Technetium Tc 99m Medronate Injection. After preparation with oxidant-free Sodium Pertechnetate Tc 99m Injection, the suggested dose range of Technetium Tc 99m Medronate Injection in the average ADULT patient (70 kg.) is: 370-740 megabecquerels: (10-20 millicuries) given intravenously. Imaging is optimal at 1 to 4 hours post Injection. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit. The patient dose should be measured by a suitable radioactivity calibration system immediately prior to administration. Radiation Dosimetry The effective half-life was assumed to be the physical half-life for all calculated values.
Source: US FDA prescribing information
Contraindications
None known.
Source: US FDA prescribing information
Warnings and precautions
This class of compounds is known to complex cations such as calcium. Particular caution should be used with patients who have, or may be predisposed to hypocalcemia (i.e., alkalosis). Preliminary reports indicate impairment of brain scans using Sodium Pertechnetate Tc 99m Injection which have been preceded by a bone scan using an agent containing stannous ions. The impairment may result in false-positive or false-negative brain scans. It is recommended, where feasible, that brain scans precede bone imaging procedures. Alternatively, a brain imaging agent such as Technetium Tc 99m Pentetate Injection may be employed. The biodistribution of technetium Tc 99m medronate may be altered in the presence of high levels of certain cations (iron, calcium, and aluminum).
Source: US FDA prescribing information
Side effects
Several adverse reactions due to Technetium Tc 99m Medronate Injection have been reported. These were usually hypersensitivity reactions characterized by itching, various skin rashes, hypotension, chills, nausea, and vomiting. There have also been rare cases of dizziness and asthenia associated with the use of Technetium Tc 99m Medronate.
Source: US FDA prescribing information
Storage
Store the product as supplied at 20-25°C (68-77°F). After reconstitution store at 20-25°C (68-77°F).
Source: US FDA prescribing information
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
All presentations
2 presentations of Technetium tc-99m medronate, sorted by availability.
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Kit for the Preparation of Technetium Tc 99M Medronate 20 mg/10 mL powder for injectionIntravenous | Sun Pharmaceutical IndustriesIndia | US FDA | Available on request |
| Kit for the Preparation of Technetium Tc 99m Medronate 20 mg powder for injectionIntravenous | Cardinal Health | US FDA | Available on request |
Brands by market
1 brand names across 1 markets.
Manufacturers
Indian manufacturers are highlighted.
Regulatory status
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
| Register | Status | Source |
|---|---|---|
| US FDA | First approved 28 November 1978 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Questions and answers
Is Technetium tc-99m medronate available for export from India?
Yes, on request. MedsAcross lists 2 presentations of Technetium tc-99m medronate and sources them for licensed hospitals, importers and physicians against valid import documents. Indian manufacturers include Sun Pharmaceutical Industries.
What brand names does Technetium tc-99m medronate have?
The catalogue lists 2 brand names for Technetium tc-99m medronate, including Kit for the Preparation of Technetium Tc 99M Medronate, Kit for the Preparation of Technetium Tc 99m Medronate.
Is Technetium tc-99m medronate approved by the US FDA?
Yes. The US FDA first approved Technetium tc-99m medronate on 28 November 1978, according to Drugs@FDA.
Does Technetium tc-99m medronate need cold chain shipping?
No listed presentation of Technetium tc-99m medronate is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
References
- Kit for the Preparation of Technetium Tc 99M Medronate prescribing information (Sun Pharmaceutical Industries). U.S. National Library of Medicine, DailyMed. Retrieved 11 March 2025
Request Technetium tc-99m medronate for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.